Enhabit (EHAB) Q1 Earnings Top Estimates
Enhabit (EHAB) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?
Here is how Enhabit (EHAB) and Doximity (DOCS) have performed compared to their sector so far this year.
Why Fast-paced Mover Enhabit (EHAB) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Surging Earnings Estimates Signal Upside for Enhabit (EHAB) Stock
Enhabit (EHAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Enhabit, Inc. (EHAB) Q4 2024 Earnings Call Transcript
Enhabit, Inc. (NYSE:EHAB ) Q4 2024 Results Conference Call March 6, 2025 10:00 AM ET Company Participants Jobie Williams - Senior Vice President and Treasurer Barb Jacobsmeyer - President and Chief Executive Officer Ryan Solomon - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Ryan Langston - TD Cowen Operator Hello, and welcome to the Enhabit Inc. Fourth Quarter 2024 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Jobie Williams, Enhabit's Senior Vice President and Treasurer.
Enhabit (EHAB) Q4 Earnings and Revenues Miss Estimates
Enhabit (EHAB) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.
Enhabit (EHAB) Is Attractively Priced Despite Fast-paced Momentum
Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Enhabit: Healthcare Predictive Analytics, FCF, Very Undervalued
EHAB's investments in healthcare predictive analytics, expected to grow at 23%-24% CAGR, could significantly boost future net income growth. Restructuring, activism, and strategic reviews are potential catalysts for stock price appreciation, enhancing financial flexibility from 2025 to 2030. Despite recent negative net income, EHAB's consistent positive cash flow and undervaluation indicate substantial upside potential in stock price.
Enhabit (EHAB) Shows Fast-paced Momentum But Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Enhabit, Inc. (EHAB) Q3 2024 Earnings Call Transcript
Enhabit, Inc. (NYSE:EHAB ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Jobie Williams – Senior Vice President and Treasurer Barb Jacobsmeyer – President and Chief Executive Officer Crissy Carlisle – Chief Financial Officer Conference Call Participants Brian Tanquilut – Jefferies A. J. Rice – UBS Ryan Langston – TD Cowen Operator Good morning, everyone and welcome to Enhabit's Home Health and Hospice's Third Quarter, 2024 Earnings Conference Call.
Enhabit (EHAB) Misses Q3 Earnings and Revenue Estimates
Enhabit (EHAB) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago.
Vanguard Group Inc's Strategic Reduction in Enhabit Inc Shares
On September 30, 2024, Vanguard Group Inc, a prominent investment firm, executed a significant transaction involving the shares of Enhabit Inc (EHAB, Financial). The firm reduced its holdings by 626,911 shares, which adjusted its total stake in the company to 2,976,480 shares.
